Stay updated with breaking news from Gamida Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gamida Cell (NASDAQ:GMDA – Get Rating) had its target price reduced by JMP Securities from $8.00 to $6.00 in a research note released on Friday morning, The Fly reports. A number of other analysts have also commented on the stock. Oppenheimer cut their price objective on shares of Gamida Cell from $10.00 to $8.00 and […]
/PRNewswire/ -- The hematopoietic stem cells transplantation (HSCT) market size is set to grow by USD 2383.61 million between 2023 and 2027, and register a...
BOSTON (AP) — BOSTON (AP) — Gamida Cell Ltd. (GMDA) on Monday reported a loss of $21 million in its first quarter.
Gamida Cell (NASDAQ:GMDA – Get Rating) will announce its earnings results after the market closes on Monday, May 15th. Analysts expect the company to announce earnings of ($0.27) per share for the quarter. Gamida Cell Stock Up 19.3 % Shares of GMDA stock opened at $2.08 on Friday. The stock has a market cap of […]
Gamida Cell (NASDAQ:GMDA – Get Rating) is scheduled to post its quarterly earnings results after the market closes on Monday, May 15th. Analysts expect Gamida Cell to post earnings of ($0.27) per share for the quarter. Gamida Cell Stock Performance Shares of GMDA opened at $2.08 on Friday. The company has a debt-to-equity ratio of […]